BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 4 , Pages 207-210 , October 2010

Feasibility of simultaneous cognitive behavioral therapy and left prefrontal rTMS for treatment resistant depression

  • Andrei Vedeniapin

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina
    • Corresponding Author InformationCorrespondence: Dr. Vedeniapin, 519 N, IOP, Medical University of South Carolina, 67 President St, Charleston, SC 29425.
    • ,
  • Laura Cheng

      Affiliations

    • College of Medicine, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Mark S. George

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina
    • Ralph H. Johnson VA Medical Center, Charleston, South Carolina

Received 31 January 2010 ,Revised 12 March 2010 ,Accepted 22 March 2010.

References 

  1. George MS, Wassermann EM, Post RM. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. J Neuropsychiatry Clin Neurosci. 1996;8(4):373–382
  2. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002;5(1):73–103
  3. Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39(1):65–75
  4. George MS, Nahas Z, Molloy M, et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry. 2000;48(10):962–970
  5. Li X, Nahas Z, Kozel FA, Anderson B, Bohning DE, George MS. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry. 2004;55(9):882–890
  6. Maier SF, Amat J, Baratta MV, Paul E, Watkins LR. Behavioral control, the medial prefrontal cortex, and resilience. Dialogues Clin Neurosci. 2006;8(4):397–406
  7. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci. 2005;8(3):365–371
  8. Amat J, Paul E, Watkins LR, Maier SF. Activation of the ventral medial prefrontal cortex during an uncontrollable stressor reproduces both the immediate and long-term protective effects of behavioral control. Neuroscience. 2008;154(4):1178–1186
  9. Huerta PT, Volpe BT. Transcranial magnetic stimulation, synaptic plasticity and network oscillations. J Neuroeng Rehabil. 2009;6:7
  10. Hebb DO. The organization of behavior: a neuropsychological theory. New York: Wiley; 1949;
  11. Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry. 2008;165(8):969–977
  12. Linden DE. How psychotherapy changes the brain—the contribution of functional neuroimaging. Mol Psychiatry. 2006;11(6):528–538
  13. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61(1):34–41
  14. de Lange FP, Koers A, Kalkman JS, et al. Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain. 2008;131(Pt 8):2172–2180

 Partial funding to Dr. Vedeniapin was provided by National Institute on Drug Abuse grant R25 DA020537.

 Mark George is an unpaid consultant to several TMS manufacturers (Neuronetics, Brainsway, Neostim, Neosync). Neuronetics loaned the TMS equipment for a recent National Institutes of Health-sponsored TMS trial in depression that Dr. George chaired. The brain stimulation laboratory is conducting a depression clinical trial funded by Brainsway. Dr. George is on the executive committee and is a site Principal Investigator for a Veterans Affairs funded multisite cooperative studies trial of TMS to treat depressed veterans (VA CSP 556).

PII: S1935-861X(10)00047-1

doi: 10.1016/j.brs.2010.03.005

BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 4 , Pages 207-210 , October 2010

Article Tools

* Image Usage & Resolution